Lantheus Holdings (LNTH) Exchange Rate Effect (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Exchange Rate Effect came in at -$22000.0 in Q1 2026, down 121.57% year-on-year from $102000.0 in Q1 2025, and up 97.11% on a QoQ basis from -$760000.0 in Q4 2025.
Lantheus Holdings (LNTH) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Exchange Rate Effect data on file, last reported at -$22000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 121.57% year-over-year to -$22000.0 in Q1 2026; TTM through Mar 2026 was -$173000.0, a 89.62% increase from a year earlier, with the FY2025 full-year figure at -$49000.0, up 95.09% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$22000.0, up from -$760000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for LNTH reached as high as $827000.0 in Q2 2025 and fell as low as -$1.0 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged -$93562.5 across 5 years, with a median of -$83500.0 in 2022.
- On a YoY basis, Exchange Rate Effect climbed as much as 885.71% in 2024 and fell as far as 514.77% in 2024.
- Year by year, Exchange Rate Effect stood at -$69000.0 in 2022, then tumbled by 236.23% to -$232000.0 in 2023, then plunged by 344.83% to -$1.0 million in 2024, then grew by 26.36% to -$760000.0 in 2025, then soared by 97.11% to -$22000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$22000.0 in Q1 2026, -$760000.0 in Q4 2025, and -$218000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | -22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Dec 31, 2025 | -760,000.00 |
| Dec 31, 2025 | -760,000.00 |
| Sep 30, 2025 | -218,000.00 |
| Sep 30, 2025 | -218,000.00 |
| Jun 30, 2025 | 827,000.00 |
| Jun 30, 2025 | 827,000.00 |
| Mar 31, 2025 | 102,000.00 |
| Mar 31, 2025 | 102,000.00 |
| Dec 31, 2024 | -1.03 Mn |
| Dec 31, 2024 | -1.03 Mn |
| Sep 30, 2024 | 247,000.00 |
| Sep 30, 2024 | 247,000.00 |
| Jun 30, 2024 | -983,000.00 |
| Jun 30, 2024 | -983,000.00 |
| Mar 31, 2024 | 770,000.00 |
| Mar 31, 2024 | 770,000.00 |
| Dec 31, 2023 | -232,000.00 |
| Dec 31, 2023 | -232,000.00 |